Delivery Order SPE2DB20D2002-SPE2DB25FL76H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $12,586.41 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $13,387.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing one...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a commonly prescribed medication for diabetes management,...
- The Defense Logistics Agency awarded a $15,724.17 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by September 16, 2025. The order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jardiance is a widely prescribed medication for managing type 2...
- The Defense Logistics Agency awarded a delivery order valued at $12,468.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to manage...
- The Defense Logistics Agency awarded a delivery order valued at $19,965.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $68,604.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, aligning with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL76HDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,287.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is part of the broader pharmaceutical support required by federal military and healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying medications and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The company's extensive portfolio and proven capability to compete and deliver across multiple therapeutic domains through the DLA supply chain make it well-positioned to fulfill the government's ongoing pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 9/15/25 |